GLP1R and type 2 diabetes mellitus: To evaluate the potential synergistic effects of GLP-1 RAs and SGLT2is, Patel et al. carried out a retrospective cohort study including adult patients with T2DM, body mass index (BMI) ≥ 27 kg/m2, and HFpEF who were receiving SGLT2i therapy.